Overview

A Study to Test the Safety and Tolerability of Brivaracetam in Pediatric Study Participants With Seizures

Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the long-term safety and tolerability of brivaracetam.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Biopharma SRL
Treatments:
Brivaracetam